12
Views
9
CrossRef citations to date
0
Altmetric
Original Article

HLA Studies in Fibromyalgia

, , , &
Pages 21-27 | Published online: 16 Jan 2010

References

  • Wolfe F: Fibroinyalgia: The Clinical Syndrome. Rheum Dis Clin North Am 15: 1–18, 1989.
  • Yunus MB: Research in Fibromyalgia and Myofascial Pain Syndrome: Current Status, Problems and Future Directions. J Musculoske Pain 10): 23–41, 1993.
  • Goldenberg DL: Fibromyalgia Syndrome. An Emerging but Controversial Condition, JAMA 257: 2782–7, 1987.
  • Wolfe F, Cathey MA: Prevalence of Primary and Secondary Fibrositis. J Rheumatol 10: 965–8, 1983.
  • Muller W: The Fibrositis Syndrome: Diagnosis, Differential Diagnosis and Pathogenesis. Scant] J Rheumatol suppl 65: 40–53, 1987.
  • Reilly PA, Littlejohn GO: Fibromyalgia and Chronic Fatigue Syndrome. Curr Opin Rheumatol 2: 282–90, 1990.
  • Pellegrino MJ, Waylonis OW, Sommer A: Familial Occurrence of Primary Fibromyalgia. Arch Phys Med Rehabil 70: 61–3, 1989.
  • Caro XJ: Is There an Immunologic Component to the Fibrositis Syn-drome? Rheutn Dis Clin North Am 15: 169–86, 1989.
  • Stortnorken H, Brosstad F: Fibromyalgia: Family Clustering and Sensory Urgency with Early Onset Indicate Genetic Predisposition and thus a "True" Dis-ease. Scand J Rheumatol 21: 207, 1992.
  • Caro Xi: Immunofluorescent Detection of IgG at the Dermal-Epidermal Junction in Patients with Apparent Primary Fibrositis Syndrome. Arthritis Rheum 27: 1174–9, 1984.
  • Caro Xi: Immunofluorescent Studies of Skin in Primary Fibrositis Syn-drome. Am J Med 81 (suppl 3A): 43–9, 1986.
  • Dinereman H, Goldenberg DL, Felson DT et al.: A Prospective Evaluation of 118 Patients with Fibromyalgia Syndrome: Prevalence of Raynaud's Phenome-non, Sicca Syndrome, AAN's, Low Complement and Ig Deposition at the Der-mal-Epidermal Junction. J Rheumatol 13: 368–73, 1986.
  • Burda CD, Cox FR, Osborne P: Histocompatibility Antigens in the Fibrosi-tis (Fibrotnyalgia) Syndrome. Clin Exp Rheum 4: 355–7, 1986.
  • Horven S, Stiles TC, Hoist A, Moen T: HLA Antigens in Primary Fibro-myalgia Syndrome. J Rheumatol 19: 1269–70, 1982.
  • Wolfe F, Smythe HA, Yunus Metal: The American College of Rheumatol-ogy 1990 Criteria for the Classification of Fibromyalgia: Report of the Multicent-er Criteria Committe: Arthritis Rheum 33: 160–72, 1990.
  • Staff: Transplantation and Immunology Branch. NIH Lymphocyte Micro-cytotoxicity Technique. In: Ray JG, ed. Niaid Manual of Tissue Typing Tech-niques, U.S. Department of Health, Education and Welfare Public, Bethesda, Maryland 80 (545): 39–41, 1979.
  • Werner CH, Klonda PT, Correa MC, Vassali P, Jeannet M: Isolation of B and T lymphocytes by nylon fiber columns. Tissue Antigens 9: 227–229, 1977.
  • Caetano JAM, Miranda JMSL, Sancho MR, Zillido R: Study of Genetic Differences Between Portuguese and Other Populations. In: European Histocom-patibility Conference Compendium of Abstracts, Strasbourg 145A-B, 1990.
  • Sewell H: HLA and Disease. Non-Inherited Maternal HLA Antigens. Lan-cet 341: 211, 1993.
  • Palmares J, Castro-Correia J, Coutinho MF, Mendes A, Delgado L: HLA and Idiopathic Uveitis. Ocular Immunol Inflam 1: 179–85, 1993.
  • Stastny P: Association of the B-Cell Alloantigen DRw4 with Rheumatoid Arthritis. N Engl J Med 298: 869–71, 1978.
  • Salvarani C, Macchioni P, Zizzi F et at.: Epidemiologic and Immunogenet-ic Aspects of Polymyalgia Rheunnatica and Giant Cell Arthritis in Northern Italy. Arthritis Rheum 34: 351–6, 1991.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.